The name describes a different kind of molecule
NAD+ stands for nicotinamide adenine dinucleotide. It is a coenzyme involved in cellular reactions, including processes associated with energy metabolism. A peptide is a chain of amino acids. Those are different chemical descriptions, so calling every item in an anti-aging catalog a peptide creates confusion before any discussion of price or evidence begins.
The distinction is useful for consumers because category names can influence expectations. A product placed beside a growth-hormone-related peptide does not acquire that peptide's mechanism. Read the actual ingredient name and formulation rather than relying on the navigation category.
NAD+ and its precursors are related, not identical
Nicotinamide riboside, often abbreviated NR, and nicotinamide mononucleotide, or NMN, are discussed in research on NAD+ metabolism. They are not alternative spellings for an NAD+ prescription. A study using one of these substances examines that intervention under its own conditions.
This matters in shopping as well as science. Restore refers to both NAD+ and Niagen or NR offerings. A quote should identify which substance is involved. Comparing an NR infusion with an NAD+ vial as though the only difference were price would conceal a change in the intervention itself.
Biological importance does not establish a need to buy
A molecule can be essential to normal biology without a commercial preparation being proven to improve a particular person's health. The observation that NAD+ participates in important cellular pathways is not a diagnosis of deficiency, a promise of improved energy or a reason to skip assessment of persistent symptoms.
When a provider explains a mechanism, ask what clinical outcome has been measured with the proposed product and route. The answer may be limited or uncertain. That uncertainty is more informative than filling the gap with a broad statement that the body needs the molecule.
Do not transfer mechanisms across catalog neighbors
Sermorelin is discussed in relation to growth-hormone signaling. NAD+ is not sermorelin, and placing the products next to each other does not justify describing NAD+ as a pituitary-signaling peptide. Our Strut review notes a mismatched tile on its NAD+ page for exactly this reason: the explanation should match the actual ingredient.
Likewise, product format is a separate question from molecular identity. A nasal preparation remains a different route from an injection even if the ingredient name is the same. Neither the molecule's name nor the route alone establishes an expected benefit.
Use precise names in the consultation and budget
Write down the full ingredient name, route and formulation when requesting a quote. Ask the clinician to distinguish the proposed product from related precursors, supplements and peptide therapies if the terminology is unclear. This makes both medical questions and price comparisons more concrete.
The cost guide keeps NAD+ entries separate by route and preserves unknown product details rather than merging them into one longevity category. That organization does not imply a recommendation to use any route. It helps the reader evaluate a real offer while keeping the basic chemistry, the evidence and the commercial terms from being mistaken for one another.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.
- PubChem: Nicotinamide adenine dinucleotide Chemical reference
- NLM MeSH: Peptides Chemical reference
- Yoshino et al. 2021: NMN and muscle insulin sensitivity in prediabetic women Clinical research
- Restore Hyper Wellness NAD+ IV Drip Therapy Provider
- Strut Health NAD+ Therapy Provider